GlassScriptPhysician profile
Parker Green
NPI 1407599582
$1,699.72
in general payments reported to CMS, 2019-2025
12 companies · $1,540 in 2025
The $1,540 reported for 2025 was more than what 97% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $160 · 2025: $1,540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,549 · Travel and Lodging: $76.13 · Education: $74.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,549.29 |
| Travel and Lodging | $76.13 |
| Education | $74.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $616.60 | 2024-2025 | Smartlock, Na, N/A |
| Depuy Synthes Sales INC. | $580.35 | 2025 | Matrixmandible |
| Axogen | $144.00 | 2025 | |
| Aroa Biosurgery Incorporated | $77.31 | 2025 | |
| Medical Device Business Services, INC. | $74.30 | 2025 | |
| Straumann USA LLC | $41.72 | 2025 | |
| Solventum Corporation | $34.73 | 2025 | Abthera Advance, V.A.C.Ulta, V.A.C. Veraflo |
| Kls-Martin L.P. | $34.08 | 2025 | |
| Geistlich Pharma, North America, INC. | $33.24 | 2025 | Biomaterials |
| Shionogi INC | $25.25 | 2025 | Fetroja |
| Teleflex LLC | $23.18 | 2025 | Quikclot |
| Pylant Medical | $14.96 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parker Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.